{"protocolSection":{"identificationModule":{"nctId":"NCT01461720","orgStudyIdInfo":{"id":"FF-115-2011"},"organization":{"fullName":"National University of Malaysia","class":"OTHER"},"briefTitle":"Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct","officialTitle":"An Open Lable, Phase II Exploratory Study Assessing the Efficacy of Intravenous Autologous Mesenchymal Stem Cells in Patients With Middle Cerebral Artery Infarct"},"statusModule":{"statusVerifiedDate":"2015-03","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-03"},"primaryCompletionDateStruct":{"date":"2015-12","type":"ESTIMATED"},"completionDateStruct":{"date":"2016-03","type":"ESTIMATED"},"studyFirstSubmitDate":"2011-10-25","studyFirstSubmitQcDate":"2011-10-26","studyFirstPostDateStruct":{"date":"2011-10-28","type":"ESTIMATED"},"lastUpdateSubmitDate":"2015-03-30","lastUpdatePostDateStruct":{"date":"2015-04-01","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Dr Norlinah Mohamed Ibrahim","investigatorTitle":"Consultant Neurologist","investigatorAffiliation":"National University of Malaysia"},"leadSponsor":{"name":"National University of Malaysia","class":"OTHER"},"collaborators":[{"name":"Cytopeutics Sdn. Bhd.","class":"INDUSTRY"}]},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"This study aims to determine the efficacy of intravenous transplantation of autologous bone marrow-derived mesenchymal stem cells in patients with acute middle cerebral artery infarct."},"conditionsModule":{"conditions":["Middle Cerebral Artery Infarction"],"keywords":["Bone marrow","Autologous","Mesenchymal stem cells","Unilateral middle cerebral artery infarct"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":50,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Standard medical care","type":"OTHER","description":"This is the control arm, which is given the best evidence-based standard treatment for the management of acute stroke","interventionNames":["Other: Standard medical care"]},{"label":"BM-MSCs","type":"EXPERIMENTAL","description":"Autologous bone marrow-derived mesenchymal stem cells(BM-MSCs)","interventionNames":["Other: Standard medical care","Biological: Autologous bone marrow-derived mesenchymal stem cells"]}],"interventions":[{"type":"OTHER","name":"Standard medical care","description":"Standard medical care includes treatment to prevent recurrence, optimal control of risk factors and post stroke follow-up rehabilitative treatment.","armGroupLabels":["BM-MSCs","Standard medical care"]},{"type":"BIOLOGICAL","name":"Autologous bone marrow-derived mesenchymal stem cells","description":"Single intravenous infusion of autologous bone marrow-derived mesenchymal stem cells concurrently with standard medical care.","armGroupLabels":["BM-MSCs"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Change in NIH Stroke Scale","timeFrame":"1 year"},{"measure":"Change in Barthel Index","timeFrame":"1 year"},{"measure":"Change in modified Rankin Scale","timeFrame":"1 year"},{"measure":"Change in size of infarct based on brain MRI stroke sequences","timeFrame":"1 year"}],"secondaryOutcomes":[{"measure":"Change in Stroke Specific Quality of Life Scale","timeFrame":"1 year"},{"measure":"Change in Stroke Impact Scale","timeFrame":"1 year"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Experiences stroke onset within 2 weeks to 2 months\n* NIHSS score of \\>10-35\n* Never received or failed thrombolysis\n* Evidence of unilateral middle cerebral artery infarct on brain MRI\n\nExclusion Criteria:\n\n* Medically unfit (eg. those are unstable haemodynamically despite treatment, with worsening conscious level and with other serious medical co-morbidity)\n* Evidence of any tumor or other space-occupying lesion on brain MRI\n* Evidence of hemorrhagic stroke on brain CT or MRI\n* Experiences transient ischemic attack or lacunar infarct\n* Has any acute or chronic infections such as Hepatitis B, Hepatitis C and HIV\n* Is diagnosed with concurrent malignancy or primary hematological disorders\n* Renal impairment indicated with serum creatinine greater than 200 umol/l or creatinine clearance less than 30 ml/min\n* Liver impairment indicated with serum aspartate transaminase and serum alanine transaminase greater than 4 times upper limit of the normal range\n* Any contraindication to stem cell transplantation or bone marrow biopsy\n* Any co-morbidity which will compromise the ability to obtain adequate stem cells (eg. chronic debilitating diseases, frail patients and patients with known osteoporosis)\n* Any contraindication to brain MRI (eg. metal implants, pacemaker, joint implants and ocular implants)","healthyVolunteers":false,"sex":"ALL","minimumAge":"30 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Norlinah Mohamed Ibrahim, MD","role":"CONTACT","email":"norlinah@ppukm.ukm.edu.my, norlinah@gmail.com"}],"overallOfficials":[{"name":"Norlinah Mohamed Ibrahim, MD","affiliation":"UKM Medical Centre","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"UKM Medical Centre","status":"RECRUITING","city":"Kuala Lumpur","zip":"56000","country":"Malaysia","contacts":[{"name":"Norlinah Mohamed Ibrahim, MD","role":"CONTACT"},{"name":"Norlinah Mohamed Ibrahim, MBBCH,MRCP,BAO","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Hui-Jan Tan, MRCP, MMed","role":"SUB_INVESTIGATOR"}],"geoPoint":{"lat":3.1412,"lon":101.68653}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020244","term":"Infarction, Middle Cerebral Artery"},{"id":"D000007238","term":"Infarction"}],"ancestors":[{"id":"D000007511","term":"Ischemia"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000009336","term":"Necrosis"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000002539","term":"Cerebral Arterial Diseases"},{"id":"D000020765","term":"Intracranial Arterial Diseases"},{"id":"D000020521","term":"Stroke"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M9972","name":"Infarction","asFound":"Infarct","relevance":"HIGH"},{"id":"M21759","name":"Infarction, Middle Cerebral Artery","asFound":"Middle Cerebral Artery Infarct","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M5478","name":"Cerebral Arterial Diseases","relevance":"LOW"},{"id":"M22211","name":"Intracranial Arterial Diseases","relevance":"LOW"},{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"}]}},"hasResults":false}